Cargando…

Social distancing, home-infusion and oral therapy: Evolving paradigms on Gaucher disease management in Spain during COVID-19 pandemic

Detalles Bibliográficos
Autores principales:	Andrade-Campos, Marcio M., Azuara, Beatriz Escuder, Perez-Valero, Conchita, de Frutos, Laura Lopez, Gonzalo, Irene Serrano, Pilar on behalf of GEEDL Giraldo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academic Press 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849601/ http://dx.doi.org/10.1016/j.ymgme.2020.12.013

Ejemplares similares

Direct and indirect effects of the SARS-CoV-2 pandemic on Gaucher Disease patients in Spain: Time to reconsider home-based therapies?
por: Andrade-Campos, Marcio, et al.
Publicado: (2020)

Recommendations on the follow‐up of patients with Gaucher disease in Spain: Results from a Delphi survey
por: Giraldo, Pilar, et al.
Publicado: (2022)

Identification of risk features for complication in Gaucher’s disease patients: a machine learning analysis of the Spanish registry of Gaucher disease
por: Andrade-Campos, Marcio M., et al.
Publicado: (2020)

Novel Management and Screening Approaches for Haematological Complications of Gaucher’s Disease
por: Giraldo, Pilar, et al.
Publicado: (2021)

Muscle-tendon weakness contributes to chronic fatigue syndrome in Gaucher’s disease
por: Roca-Espiau, Mercedes, et al.
Publicado: (2019)

Advantages of digital technology in the assessment of bone marrow involvement in Gaucher's disease
por: Valero-Tena, Esther, et al.
Publicado: (2023)

Gaucher disease and chronic myeloid leukemia: first reported patient receiving enzyme replacement and tyrosine kinase inhibitor therapies simultaneously
por: Noya, MSoledad, et al.
Publicado: (2018)

P1540: STUDY OF MIRNA EXPRESSION PROFILES IN GAUCHER PATIENTS AND THEIR RELATIONSHIP WITH THE SEVERITY OF BONE INVOLVEMENT
por: Serrano-Gonzalo, I., et al.
Publicado: (2022)

Serum Phospholipid Profile Changes in Gaucher Disease and Parkinson’s Disease
por: López de Frutos, Laura, et al.
Publicado: (2022)

Therapeutic Potential of αS Evolvability for Neuropathic Gaucher Disease
por: Wei, Jianshe, et al.
Publicado: (2021)

Diagnosis features of pediatric Gaucher disease patients in the era of enzymatic therapy, a national-base study from the Spanish Registry of Gaucher Disease
por: Andrade-Campos, Marcio, et al.
Publicado: (2017)

Mapping the genetic and clinical characteristics of Gaucher disease in the Iberian Peninsula
por: Giraldo, Pilar, et al.
Publicado: (2012)

Demographics and patient characteristics of 1209 patients with Gaucher disease: Descriptive analysis from the Gaucher Outcome Survey (GOS)
por: Zimran, Ari, et al.
Publicado: (2017)

Switching between Enzyme Replacement Therapies and Substrate Reduction Therapies in Patients with Gaucher Disease: Data from the Gaucher Outcome Survey (GOS)
por: Hughes, Derralynn A., et al.
Publicado: (2022)

Gaucher Disease and Gaucher Cells
por: Gözdaşoğlu, Sevgi
Publicado: (2015)

An evolving paradigm for the secretory pathway?
por: Lippincott-Schwartz, Jennifer
Publicado: (2011)

The evolving treatment paradigm in myelofibrosis
por: Mesa, Ruben A.
Publicado: (2013)

Evolving Paradigms in Melanoma Therapy
por: Olszanski, Anthony J., et al.
Publicado: (2016)

Evolving paradigm in thrombophilia screening
por: Ashraf, Noman, et al.
Publicado: (2019)

Evolving treatment paradigms for PCV
por: Fenner, Beau J., et al.
Publicado: (2021)

Management goals of type 1 Gaucher disease in South Africa: An expert Delphi consensus document on good clinical practice
por: Louw, Vernon Johan, et al.
Publicado: (2023)

The Influence of Genetic Variability and Proinflammatory Status on the Development of Bone Disease in Patients with Gaucher Disease
por: Gervas-Arruga, Javier, et al.
Publicado: (2015)

The cognitive profile of type 1 Gaucher disease patients
por: Biegstraaten, Marieke, et al.
Publicado: (2012)

The evolving paradigm of tissue-specific metastasis
por: DiMeo, Theresa A, et al.
Publicado: (2006)

Surgical management of glaucoma: Evolving paradigms
por: Sharaawy, Tarek, et al.
Publicado: (2011)

Evolving paradigms in cardiogenic shock care
por: Tehrani, Behnam N., et al.
Publicado: (2019)

Evolving treatment paradigms in esophageal cancer
por: Turgeman, Ilit, et al.
Publicado: (2021)

Smart Biomaterials: An Evolving Paradigm in Dentistry
por: Rathi, Harsha P, et al.
Publicado: (2023)

Global DNA cytosine methylation as an evolving trait: phylogenetic signal and correlated evolution with genome size in angiosperms
por: Alonso, Conchita, et al.
Publicado: (2015)

Gaucher Cells or Pseudo-Gaucher Cells: That’s the Question
por: Gören Şahin, Deniz, et al.
Publicado: (2014)

Neuropathological Features of Gaucher Disease and Gaucher Disease with Parkinsonism
por: Furderer, Makaila L., et al.
Publicado: (2022)

The Evolving Paradigm in the Management of Intracranial Atherosclerotic Disease
por: Ozturk, Ali K., et al.
Publicado: (2012)

Seasonal Malaria Chemoprevention: An Evolving Research Paradigm
por: Snow, Robert W.
Publicado: (2016)

Nonalcoholic fatty liver disease: Evolving paradigms
por: Lonardo, Amedeo, et al.
Publicado: (2017)

Immunotherapy in endometrial cancer - an evolving therapeutic paradigm
por: Longoria, Teresa C., et al.
Publicado: (2015)

The role of penectomy in penile cancer—evolving paradigms
por: O’Neill, Sarah, et al.
Publicado: (2020)

The evolving treatment paradigm of lung cancer in China
por: Xie, Wei, et al.
Publicado: (2022)

Evolving paradigms for natural-product drug discovery
por: Cordell, Geoffrey A
Publicado: (2022)

Respiratory Viruses in Nosocomial Pneumonia: An Evolving Paradigm
por: Zilberbeg, Marya D., et al.
Publicado: (2023)

Gaucher's disease
por: Bohra, Vijay, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_4klqfkgn58tdatl5rmv4upaasj